Integral Vision (INVI) 424B3 Prospectus supplement

Filed pursuant to Rule 424(b)(3)

Registration Statement File No. 333-125669

PROSPECTUS SUPPLEMENT DATED AUGUST 14, 2007

TO

PROSPECTUS DATED MAY 2, 2006

as amended by Post-Effective Amendment No. 2 dated April 2, 2007 and

as supplemented on May 15, 2007

INTEGRAL VISION, INC.

This prospectus supplement should be read in conjunction with our prospectus dated May 2, 2006, as amended by Post-Effective Amendment No. 2 dated April 2, 2007 and as supplemented on May 15, 2007, in particular the “Risk Factors” beginning on page 5 of the prospectus.

This prospectus supplement includes the attached Quarterly Report on Form 10-QSB of Integral Vision, Inc. that was filed with the Securities and Exchange Commission on August 14, 2007.

United States Securities And Exchange Commission
Washington, D.C. 20549

FORM 10-QSB

x	Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
	For the quarterly period ended June 30, 2007.
o	Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
	For the transition period from ___________ to _____________.

Commission File Number0-12728

INTEGRAL VISION, INC.
(Exact name of registrant as specified in its charter)

Michigan	38-2191935
(State or other jurisdiction of incorporation or	(I.R.S. Employer Identification Number)
organization)
49113 Wixom Tech Drive
Wixom, Michigan	48393
(Address of principal executive offices)	(Zip Code)
Registrant's telephone number, including area code:    (248) 668-9230

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.YESoNOx

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).YESoNOx

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).YESoNOx

The number of shares outstanding on each of the issuer's classes of common stock, as of the latest practicable date: As of August 8, 2007:

Common Stock, No Par Value, Stated Value $.20 Per Share – 29,566,409

Transitional Small Business Format (check one):YESoNOx

INTEGRAL VISION, INC.

FORM 10-QSB Report
June 30, 2007

TABLE OF CONTENTS

PART I.	FINANCIAL INFORMATION
Item 1.	Financial Statements (Unaudited)	3
	Condensed Balance Sheets (unaudited)
	as of June 30, 2007 and December 31, 2006	3-4
	Condensed Statements of Operations
	(unaudited) for the three months and the six months ended
	June 30, 2007 and 2006	5-6
	Statement of Stockholders’ Deficit (unaudited)	7
	Condensed Statements of Cash Flows
	(unaudited) for the six months ended
	June 30, 2007 and 2006	8
	Notes to Condensed Financial Statements (unaudited)	9
Item 2.	Management’s Discussion and Analysis of
	Financial Condition and Results of Operations	17
Item 3.	Controls and Procedures	22
PART II.	OTHER INFORMATION
Item 6.	Exhibits	23
	Signatures	24

2

INTEGRAL VISION, INC.
Condensed Balance Sheets

		June 30,		December 31,
		2007			2006
		(Unaudited)
		(in thousands)
Assets
Current assets:
Cash	$	59		$	57
Accounts receivable		137			21
Inventories - Note A		531			381
Other current assets		50			119
Total current assets		777			578
Property and equipment:
Builidng Improvements		4			4
Production and engineering equipment		234			203
Furniture and fixtures		80			80
Computer equipment		189			188
Marketing/demonstration equipment		161			161
		668			636
Less accumulated depreciation		(402	)		(369	)
Net property and equipment		266			267
Other assets - net of accumulated ammortization of $1,490,000
($1,483,000 for 2006)		33			36
	$	1,076		$	881

See notes to condensed financial statements.

3

INTEGRAL VISION, INC.
Condensed Balance Sheets – Continued

Current liabilities:
Notes payable	$	2,227		$	350
Accounts payable		160			170
Accrued compensation and related costs		307			308
Accrued interest		113			17
Other accrued liabilities		69			78
Deferred revenue for product sales		183			-
Total current liabilities		3,059			923
Long-term debt					378
Total liabilities		3,059			1,301
Stockholders' deficit:
Preferred stock, 400,000 shares authorized; none issued		-			-
Common stock, without par value, stated value $.20
per share; 41,000,000 shares authorized; 29,511,409 shares issued
and outstanding (29,491,409 in 2006)		5,902			5,898
Additional paid-in capital		39,342			39,296
Accumulated deficit		(47,227	)		(45,614	)
Total stockholders’ deficit		(1,983	)		(420	)
	$	1,076		$	881

See notes to condensed financial statements.

4

     INTEGRAL VISION, INC.
Condensed Statements of Operations

		Three Months Ended June 30,
		2007			2006
		(Unaudited)
Revenue:		(In thousands, except per share data)
Net product sales	$	94		$	290
Net revenue from product development agreements		-			48
Total revenues (See Note-B)		94			338
Costs of sales:
Costs of sales for products		81			151
Cost of sales for product development agreements		-			51
Depreciation and amortization		4			23
Total costs of sales		85			225
Gross margin		9			113
Other costs and expenses:
Marketing		163			194
General and administrative - net		361			355
Engineering and development - net		264			330
Total other costs and expenses		788			879
Operating loss		(779	)		(766	)
Other income (deductions)		-			(1	)
Interest income		-			13
Interest expense		(87	)		(8	)
Net loss	$	(866	)	$	(762	)
Basic and diluted loss per share:
Net loss	$	(0.03	)	$	(0.03	)
Weighted average number of shares of common stock and
common stock equivalents, where applicable		29,511			29,491

See notes to condensed financial statements.

5

     INTEGRAL VISION, INC.
Condensed Statements of Operations

		Six Months Ended June 30,
		2007			2006
		(Unaudited)
Revenue:		(In thousands, except per share data)
Net product sales	$	410		$	305
Net revenue from product development agreements		-			102
Total revenues (See Note-B)		410			407
Costs of sales:
Costs of sales for products		336			199
Cost of sales for product development agreements		-			104
Depreciation and amortization		10			44
Total costs of sales		346			347
Gross margin		64			60
Other costs and expenses:
Marketing		312			326
General and administrative - net		679			667
Engineering and development - net		580			657
Total other costs and expenses		1,571			1,650
Operating loss		(1,507	)		(1,590	)
Other income		5			10
Interest income		-			35
Interest expense		(111	)		(15	)
Net loss	$	(1,613	)	$	(1,560	)
Basic and diluted loss per share:
Net loss	$	(0.05	)	$	(0.05	)
Weighted average number of shares of common stock and
common stock equivalents, where applicable		29,509			29,491

6

INTEGRAL VISION, INC.
Statement of Stockholders' Deficit

	Common Stock
	Number of
	Shares			Additional Paid-			Accumulated
	Outstanding	Amount		In Capital			Deficit			Total
	(in thousands, except number of common shares outstanding)
Balance at January 1, 2007	29,491,409	$	5,898	$	39,296		$	(45,614	)	$	(420	)
Issuance of 20,000 shares
common stock from
exercise of options	20,000		4		(2	)					2
Net loss for the period								(1,613	)		(1,613	)
Share based compensation					48						48
Balance at June 30, 2007	29,511,409	$	5,902	$	39,342		$	(47,227	)	$	(1,983	)

See notes to condensed financial statements.

7

     INTEGRAL VISION, INC.
Condensed Statements of Cash Flows

		Six Months Ended June 30,
		2007			2006
		(Unaudited)
		(in thousands)
Cash Flows From Operating Activities
Net loss	$	(1,613	)	$	(1,560	)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation		38			16
Amortization		6			42
Share-based compensation		48			80
Changes in operating assets and liabilities:
Accounts receivable		(116	)		(182	)
Inventories		(150	)		(201	)
Prepaid and other		69			29
Accounts payable and other current liabilities		77			169
Deferred revenue		183			71
Net Cash Used In Operating Activities		(1,458	)		(1,536	)
Cash Flows From Investing Activities
Purchase of property and equipment		(38	)		(48	)
Additional Patents		(3	)		(7	)
Net Cash Used In Investing Activities		(41	)		(55	)
Cash Flows From Financing Activities
Proceeds from sale of Class 2 Notes - Net		1,499			-
Proceeds from Issuance of common stock		2			-
Net Cash Provided By Financing Activities		1,501			-
Increase ('Decrease) in Cash		2			(1,591	)
Cash at Beginning of Period		57			2,501
Cash at End of Period	$	59		$	910
Supplemental cash flows disclosure:
Interest Paid	$	15		$	15
Reclassification of inventory to fixed assets		-		$	153

See notes to condensed financial statements.

8

Notes to Condensed Financial Statements
Integral Vision, Inc.

The condensed financial statements in this report have been prepared by Integral Vision, Inc. without audit, pursuant to the rules of the Securities and Exchange Commission for quarterly reports on Form 10-QSB and do not include all of the information and note disclosures required by accounting principles generally accepted in the United States of America for annual financial statements. These statements should be read in conjunction with the financial statements and notes for the year ended December 31, 2006, included in our form 10-KSB filed with the Securities and Exchange Commission on March 19, 2007.

In the opinion of management, information included in this report reflects all adjustments, consisting only of normal, recurring adjustments, necessary for fair presentation of results for these interim periods.

The results of operations for the three month and six month periods ended June 30, 2007 are not necessarily indicative of the results to be expected for the entire year ending December 31, 2007.

Note A – Nature of Business

Integral Vision, Inc. develops, manufactures, and markets flat panel display inspection systems to ensure product quality in the display manufacturing process. We primarily inspect Microdisplays and small flat panel displays, though the technology used is scalable to allow inspection of full screen displays and components. Our customers and potential customers are primarily large companies with significant investment in the manufacture of displays. Nearly all of our sales originate in the United States, Asia, or Europe. Our products are generally sold as capital goods. Depending on the application, display inspection systems have an indefinite life and are more likely to require replacement due to possible technological obsolescence than from physical wear.

In 2006, we began activity associated with a product development agreement where we are compensated for a portion of our development costs for a certain best efforts product development. We may not be able to find future opportunities like this, but remain open to such development agreements where they facilitate the Company’s strategic goals.

Note B – Significant Accounting Policies

Use of Estimates

The preparation of condensed financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements. Estimates also affect the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Inventories

Inventories are stated at the lower of first-in, first-out (“FIFO”) cost or market. Cost is computed using currently adjusted standards which approximates actual costs on a FIFO basis. We assess the recoverability of all inventory to determine whether adjustments for impairment are required. At June 30, 2007 and December 31, 2006, inventories consisted of the following amounts (net of obsolescence reserves of $79,000 at June 30, 2007 and $79,000 at December 31, 2006):

9

		30-Jun-07	31-Dec-06
	(in thousands)
Raw materials	$	257	$	214
Work in process		138		167
Finished goods		136		-
	$	531	$	381

Management periodically performs an analysis of our inventory to determine if its cost exceeds estimated net realizable value.

Deferred Revenue

Deferred revenue represents amounts periodically invoiced for sales orders in excess of amounts recognized as revenues. At June 30, 2007 there was deferred revenue for product sales of $183,000. At December 31, 2006 there was no deferred revenue.

Revenue Recognition

We recognize revenue in accordance with SOP 97-2, Software Revenue Recognition, Staff Accounting Bulletin No. 101 (“SAB 101”), and Staff Accounting Bulletin No. 104 (“SAB 104”) Revenue Recognition in Financial Statements. Revenue is recognized when persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the selling price is fixed or determinable and collectibility is reasonably assured.

We account for certain product sales of our flat panel display inspection systems as multiple-element arrangements. If specific customer acceptance requirements are met, the Company recognizes revenue for a portion of the total contract price due and billable upon shipment, with the remainder recognized when it becomes due (generally upon acceptance). We recognize all other product sales with customer acceptance provisions upon final customer acceptance. We recognize revenue from the sale of spare parts upon shipment. Revenue from service contracts is recognized over the life of the contract. Revenue is reported net of sales commissions of $2,989 and $8,798 for the three month and six month periods ended June 30, 2007 and $14,390 and $16,774 for the three month and six month periods ended June 30, 2006.

Revenue is also derived through business agreements for product development. We conduct specified product development projects related to one of our principal technology specializations for an agreed-upon fee. Typically the agreements require a “best efforts” with no specified performance criteria. Revenue from product development agreements, where there are no specific performance terms, are recognized in amounts equal to the amounts expended on the programs. Generally, the agreed-upon fees for product development agreements contemplate reimbursing us, after its agreed-upon cost share, if any, for costs considered associated with project activities including expenses for direct product development and research, operating, general and administrative expenses and depreciation. Accordingly, expenses related to product development agreements are recorded as cost of revenues from product development agreements.

Allocations of General and Administrative Costs and Engineering Costs

We allocate a portion of general and administrative expense and a portion of engineering expense to cost of sales from product development agreements based on a percentage of direct labor costs. These allocations are limited to the amount of revenues, after direct expenses, under the applicable agreements.

The following is a summary of the allocations made for the three-month and six-month periods ended June 30 for the years 2007 and 2006:

10

	Three Months					Six Months
	2007		2006			2007			2006
	(in thousands)					(in thousands)
Gross G&A Expense	$	361	$	362		$	687		$	683
Less allocation to cost of sales from
product development agreements		-	$	(7	)		-		$	(16	)
Less allocation to inventory for
product development agreements		-				$	(8	)		-
Remaining G&A Expense	$	361	$	355		$	679		$	667
	Three Months					Six Months
	2007		2006			2007			2006
	(in thousands)					(in thousands)
Gross Engineering Expense	$	264	$	370		$	600		$	726
Less allocation to cost of sales from
product development agreements		-	$	(40	)		-		$	(69	)
Less allocation to inventory for
product development agreements		-				$	(20	)		-
Remaining G&A Expense	$	264	$	330		$	580		$	657

Stock-Based Compensation

We account for our stock based compensation plans according to the provisions of SFAS 123R. Accordingly, compensation costs attributable to stock options or similar equity instruments granted are measured at the fair value at the grant date, and expensed over the expected vesting period. SFAS 123R requires excess tax benefits be reported as a financing cash inflow rather than as a reduction of taxes paid.

Reclassifications

Certain amounts have been reclassified in prior periods presentations to conform to the current year's presentation.

Recently Issued Accounting Standards

In February 2007, the Financial Accounting Standards Board (“FASB”) issued Statement No. 159, “The Fair Value Option for Financial Assets and Financial Liabilities” (“SFAS No. 159”). SFAS No. 159 permits entities to choose to measure many financial assets and financial liabilities at fair value. Unrealized gains and losses on items for which the fair value option has been elected will be reported in earnings. SFAS No. 159 is effective for fiscal years beginning after November 15, 2007. We are currently evaluating the impact of SFAS No. 159 on our financial position and results of operations.

Note C – Long-Term Debt and Other Financing Arrangements

The Board of Directors, at their February 28, 2007 meeting, authorized the issuance of up to $2,000,000 of Class 2 Notes. Management has made arrangements to issue up to $2,000,000 of the Notes under the terms of our existing Note and Warrant Purchase Agreement as amended. In connection with the foregoing, we entered into an amendment to the Class 2 Notes (i) extending the maturity date to July 31, 2007 ( see Note I - Subsequent Events for recent activity associated with Class 2 Notes), and (ii) granting the holders of Class 2 Notes the right to participate in future equity financings up to the face amount of their respective Notes. The foregoing amendment was made to all Class 2 Notes except for one Note for $50,000. As of June 30, 2007, $1,910,000 of these Notes have been issued, primarily to related parties, and $1,849,000 of these Notes remain outstanding. Management anticipates issuing the balance of these Notes during the third quarter of 2007. (See Note I – Subsequent Events for recent activity associated with Class 2 Notes.)

11

The Class 2 Notes are working capital notes and are secured by accounts receivable, inventory, and intellectual property. The purchasers of Class 2 Notes receive 10% interest and the option to receive either warrants for the purchase of our common stock when the Note is repaid or an additional 2% interest. Class 2 Warrants entitle the holder to purchase one share of common stock for each $1 in value of the Class 2 Note multiplied by a fraction, the numerator of which is the number of days such Class 2 Note is outstanding and the denominator of which is 365, at a specific price which shall be approximately 150% of the recent fair value of our common stock as agreed by the parties as of the date of issuance of the corresponding Class 2 Note or such other price as the Board of Directors shall determine is appropriate based on the circumstances at the time. The Board of Directors has approved a $1.60 strike price for the warrants. The Notes will mature July 31, 2007. As of June 30, 2007, the note holders had earned 555,859 warrants, none of which had been issued. (See Note I - Subsequent Events for recent activity associated with Class 2 Notes.)

As of June 30, 2007, we had $378,000 in outstanding Class 3 Notes payable that are convertible into our common stock at $1.00 per share. The Notes are due April 1, 2008, and interest is paid semi-annually at 8%. The Class 3 Notes are secured by our intellectual property.

A summary of our debt obligations is as follows:

	June 30		December 31
	2007		2006
	(in thousands)
Long Term Debt:
Class 3 Notes		-	$	378
Less Original Issue Discount (OID)		-		-
Net Long Term Debt	$	-	$	378
Short Term Debt:
Class 2 Notes	$	1,849	$	350
Class 3 Notes	$	378		-
Other Short Term Debt		-		-
Total Short Term Debt	$	2,227	$	350

Note D – Loss per Share

The following table sets forth the computation of basic and diluted loss per share:
	Three Months Ended June 30,						Six Months Ended June 30,
	2007			2006			2007			2006
	(unaudited)						(unaudited)
	(in thousands, except per share data)						(in thousands, except per share data)
Numerator for basic and diluted loss per share – loss
available to common stockholders
Net loss	$	(866	)	$	(762	)	$	(1,613	)	$	(1,560	)
*there was no effect of dilutive securities—see below
Denominator for basic and diluted loss per
share – weighted average shares		29,511			29,491			29,509			29,491
*there was no effect of dilutive securities—see below
BASIC AND DILUTED LOSS PER SHARE:
Net loss	$	(0.03	)	$	(0.03	)	$	(0.05	)	$	(0.05	)

12

Warrants and options outstanding were not included in the computation of diluted earnings per share because the inclusion of these instruments would have an antidilutive effect. For additional disclosuresregarding stock options see Note F – Stock Based Compensation.

Note E – Income Taxes

On January 1, 2007, we adopted the provisions of Financial Accounting Standards Board Interpretation No. 48, “Accounting for Uncertainty in Income Taxes” (“FIN 48”), an interpretation of FASB Statement No. 109 (“SFAS 109”). There was no impact on our financial statements upon adoption. Because of our historical significant net operating losses, we have not been subject to income tax since 1995. There were no unrecognized tax benefits during all the periods presented.

We maintain deferred tax assets that reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. These deferred tax assets include net operating loss carry forwards and credit carry forwards. The net deferred tax asset has been fully offset by a valuation allowance because of our history of losses.

We classify all interest and penalties as income tax expense. We did not have any accrued interest and penalties related to uncertain tax positions as of June 30, 2007.

We file income tax returns in the United States federal jurisdiction and various state jurisdictions. The tax years 2003 through 2006 remain open to examination by taxing jurisdictions to which we are subject. As of June 30, 2007, we did not have any tax examination in process.

Note F – Stock-Based Compensation

We currently have two active stock option plans, the 1999 and the 2004 stock option plans ( the “Plans”) which provide for options that may be granted to eligible employees, officers and directors of Integral Vision. We reserved 1,500,000 shares for future issuance under the Plans. As of June 30, 2007, there remained 429,000 shares which can be issued under the Plans.

The purpose of the Plans generally is to retain and attract persons of appropriate education, experience and ability to serve as our employees, to encourage a sense of proprietorship of such persons, and to stimulate an active interest in our development and financial success.

The Plans are administered by the Compensation Committee of the Board of Directors (the “Committee”). The Committee determines which eligible employees will receive awards, the timing and manner of the grant of such option awards, the exercise price of the stock options (which may not be less than market value on the date of grant) and the number of shares. We may at any time amend or terminate the Plans, however no amendment that would impair the rights of any participant with respect to outstanding grants can be made without the participant’s prior consent.

The fair value of each option award is estimated on the date of grant using the Black-Scholes option valuation model with the assumptions noted in the following table. The fair value of all awards is amortized on a straight line basis over the requisite service periods. The expected life of all awards granted represents the period of time that they are expected to be outstanding. The expected life is determined using historical and other information available at the time of grant. Expected volatilities are based on historical volatility of our common stock, and other factors. The risk-free rate for periods within the contractual life of the option is based on the U.S. Treasury yield curve in effect at the time of grant. We use historical data to estimate pre-vesting option forfeitures.

13

	June 30
	2007		2006
	(in thousands)
Expected Life (in years)	6.0		6.4
Expected volatility	82.87	%	101.6	%
Risk-free interest rate	4.90	%	3.68	%
Expected dividend yield	0	%	0	%
Expected forefiture rate	0	%	0	%

A summary of option activity under all plans for the six months ended June 30, 2007, and 2006 follows:

	2007					2006
		Weighted				Weighted
		Average				Average
	Shares	Exercise Price		Shares		Exercise Price
	(number of shares in thousands)
Outstanding at January 1	1,309	$	0.95	1,114		$	0.97
Granted	0		0.00	210			0.60
Exercised	20		0.10	0			0.00
Expired	61		2.86	(15	)		6.25
Outstanding at June 30
($.10 to $5.63 per share)	1,228		0.87	1,309			0.95
Exercisable ($.10 to $5.63 per share)	1,028	$	0.80	1,099		$	0.90

A summary of the status of our nonvested shares as of June 30, 2007, and changes during the six months ended June 30, 2007, is presented below:

			Weighted
			Average Grant-
			Date Fair
			Value Exercise
	Shares		Price
Nonvested at January 1, 2007	210,000		$	0.60
Granted	0			0.00
Forfeited	(10,000	)		0.60
Vested	0			0.00
Nonvested at June 30, 2007	200,000		$	0.60

The following table summarizes share-based compensation expense for the six months ended June 30, 2007 and 2006 related to share-based awards under SFAS No. 123R as recorded in the statement of operations in the following expense categories:

14

		Three Months				Six Months
		2007		2006		2007	2006
		(in thousands)				(in thousands)
Marketing	$	5	$	6	$	10	$	14
Engineering and Development		13		16		26		45
General and Administrative		6		7		12		21
Total share based compensation expense	$	24	$	29	$	48	$	80

As of June 30, 2007, we had $83,393 of unrecognized expense related to un-vested share-based compensation which will be recognized ratably as compensation expense over the remaining vesting period from July 1, 2007 through May 16, 2008.

Additional information regarding the range of exercise prices and weighted average remaining life of options outstanding at June 30, 2007 follows:

		Weighted
Range of	Number	Average	Number
Exercise Prices	Outstanding	Remaining Life	Exercisable
	(number of shares in thousands)
$.10 to $.60	669	6.1	469
$1.03 to $5.63	559	5.7	559
$.10 to $5.63	1,228	5.9	1028

A summary of the outstanding warrants, options, and shares available upon the conversion of debt at June 30, 2007 is as follows:

	Weighted			Weighted
	Average			Average
	Exercise		Number	Remaining	Number
	Price		Outstanding	Life	Exercisable
			(number of shares in thousands)
Warrants	$	1.60	3,500	2.79	3,500
Class 2 Note	$	1.00	321	1.73	321
Class 3 Notes	$	1.00	378	0.76	378
1995 Employee Stock	$	0.64	319	3.50	319
1999 Employee Stock	$	0.27	335	4.77	335
2004 Employee Stock	$	1.34	574	7.93	374
	$	1.36	5,427	3.29	5,227

Note G – Contingencies

Product Warranties

We provide standard warranty coverage for most of our products, generally for one year from the date of customer acceptance. We record a liability for estimated warranty claims based on historical claims and other factors. Management reviews these estimates on a regular basis and adjusts the warranty reserves as actual experience differs from historical estimates or other information becomes available. This warranty

15

liability primarily includes the anticipated cost of materials, labor and travel, and shipping necessary to repair and service the equipment.

The following table illustrates the changes in our warranty liability for the six months ended June 30, 2007 and 2006:

	Amount			Amount
	2007			2006
	(in thousands)
Balance as of January 1	$	49		$	80
(Charges)/credits to expense		16			-
Utilization/payment		(1	)		(3	)
Balance as of March 31	$	64		$	77
(Charges)/credits to expense		(1	)		5
Utilization/payment		(2	)		(7	)
Balance as of June 30	$	61		$	75

Note H – Going Concern Matters

The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. As shown in the financial statements, we incurred losses from operations in the six months ended June 30, 2007 and 2006 of $1,613,000 and $1,560,000, respectively. Further, during the years 2006 and 2005 we incurred losses of $3.0 million and $2.7 million, respectively. The continuing losses raise substantial doubt about our ability to continue as a going concern.

We are currently working with a number of large customers who are using our technologies to evaluate their microdisplay production or are evaluating our technology for the inspection of LCD displays and components. We expect that additional sales orders will be placed by these customers throughout 2007 and into 2008 provided that markets for these products continue to grow and the customers continue to have interest in our technology-assisted inspection systems. Ultimately, our ability to continue as a going concern will be dependent on these large companies getting their emerging display technology products into high volume production and placing sales orders with us for inspection products to support that production. However, there can be no assurance that we will be succesful in securing sales orders sufficient to continue operating as a going concern.

The Board of Directors at their February 28, 2007 meeting, authorized the issuance of up to $2,000,000 of Class 2 Notes. Effective July 23, 2007 the Board of Directors authorized an increase of $500,000 of Class 2 Notes. At their August 8, 2007 meeting the Board of Directors authorized an increase of $122,000 of Class 2 Notes. These increases allow a total of $2,622,000 of Class 2 Notes to be outstanding.

From November 2006 through August 8, 2007, we have used $2,124,000 of Class 2 Notes to fund operations leaving a balance of $498,000 of available Class 2 Notes which we expect to be funded during the third and fourth quarters of 2007. We anticipate needing an additional $2,000,000 to fund operations through the third quarter of 2008. We are in the process of reviewing various alternatives for additional funding with potential investors. We are expecting to secure these funds and refinance the existing notes in the fourth quarter of 2007, however, there can be no assurance that this will be accomplished.

The condensed financial statements do not include any adjustments that might be necessary should we be unable to continue as a going concern.

16

For further information regarding our obligations, see Note C – Long Term Debt and Other Financing Arrangements and Note I – Subsequent Events.

Note I – Subsequent Events

During the month of July 2007 we made arrangements to amend our existing Class 2 Note and Warrant Purchase Agreement with the Class 2 Note holders. The amendment provides for an increase of $500,000 to the limit for the outstanding notes, the extension of the July 31, 2007 maturity date to October 15, 2007 and the issuance of Warrants accrued on their Class 2 Notes through July 30, 2007 if requested. The number of Warrants requested by and issued to the Class 2 Note holders was 335,545. The value of the Warrants issued was $21,118 which was determined using the Black-Scholes option pricing model. The effective date of the amendment is July31, 2007 except the effective date for the requirement that accrued warrants be issued to Note holders is July 30, 2007.

During the month of August 2007 we made arrangements to further amend our existing Class 2 Note and Warrant Purchase agreement with the Class 2 Note holders. The amendment provides for an increase of $122,000 to the limit for the outstanding notes and the provision that Class 2 Note holders may elect to receive accrued Class 2 warrants at the time they amend their notes and once each calendar quarter.

During the months of July and August 2007 we made arrangements and issued $275,000 of Class 2 Notes to related parties. For further information on Class 2 Notes see Note C to the financial statements.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Forward-Looking Statements

This Quarterly Report on Form 10-QSB contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Actual results could differ materially from those projected in the forward-looking statements as a result of a number of factors, risks and uncertainties. Generally, the words “anticipate”, “expect”, “intend”, “believe” and similar expressions identify forward-looking statements. The information included in this Form 10-QSB is as of the filing date with the Securities and Exchange Commission and future events or circumstances could differ significantly from the forward-looking statements included herein. Accordingly, we caution readers not to place undue reliance on such statements.

Overview

Integral Vision, Inc., a Michigan corporation (or the "Company"), was incorporated in 1978. We develop, manufacture and market flat panel display inspection systems to ensure product quality in the display manufacturing process. We primarily inspect microdisplays and small flat panel displays, though the technology used is scalable to allow inspection of full screen displays and components. Our products primarily use machine vision to evaluate operating displays for cosmetic and functional defects, but can also provide electrical testing if required for a given application. Our customers and potential customers are primarily large companies with significant investment in the manufacture of displays. Nearly all of our sales originate in the United States, Asia, or Europe. Our products are generally sold as capital goods. Depending on the application, display inspection systems have an indefinite life and are more likely to require replacement due to possible technological obsolescence than from physical wear.

Automated inspection has become a necessity for manufacturers who need to continually improve production efficiency to meet the increasing demand for high quality products. Our automatic inspection systems can inspect parts at a lower cycle time and with greater repeatability than is possible with human inspectors. While we have several large companies as customers, these customers are working with new microdisplay

17

technologies. Our success will be substantially dependant on these customers getting their emerging display technologies into high volume production.

Products

SharpEye –Our SharpEye product provides Flat Panel Display (FPD) inspection for reflective, emissive and transmissive display technologies. SharpEye is designed for the detection of functional and cosmetic defects in LCOS, OLED, MEMS, 3LCD/HTPS, LCD and other emerging display technologies. These technologies are applied to consumer products such as camcorders, rear projection computer monitors, digital still cameras, HDTV, projectors, video headsets and video telephones. The core technology of SharpEye inspection algorithms is the ability to quantize data to the level of a single display pixel. SharpEye can be configured for production inspection or for display evaluation in a laboratory based on the equipment configuration selected.

LumenEye –Our LumenEye product provides an “out of the box” solution designed for a low skill level user to setup and acguire images from an FPD panel. It is targeted at manufacturers of FPD products who need to inspect for inherent Image Retention (Image Sticking) defects in their displays prior to shipment. The software provided with LumenEye will perform an evaluation of the panel based on the acquired images to VESA 305-2 specification. Integral Vision can also provide the customer unique Image Retention analysis as part of its software offering. Custom panel evaluation software is also available to meet the FPD manufacturer customer test pattern requirements.

ChromaSee –Our ChromaSee product provides luminance, color matching and defect inspections for FPD displays. Defect detection includes functional (e.g. failed pixels, icons) and cosmetic (e.g. scratches) defects. ChromaSee integrates with production equipment to allow inline or offline testing. A configuration interface (Task Sequencer) uses a familiar “Tree View” representation of the inspection sequence flow. For deployment into production, the operator’s interface provides essential views of results, images and statistics for production floor personnel.

Lifetime Tester –Our Lifetime Tester product evaluates changes in display luminance, color and other performance characteristics over time. The Lifetime Tester facilitates the process of comparing different display manufacturing processes and formulas by evaluating large numbers of samples side by side to determine their life characteristics. This allows design and process engineers to efficiently evaluate the effectiveness of proposed design and process changes off line prior to implementation.

IVSee – Our IVSee provides FPD inspection for applications which still require manual handling. IVSee is designed for the detection of functional and cosmetic defects in LCOS, OLED, MEMS, 3LCD/HTPS, LCD and other emerging display technologies. IVSee is configured to be integrated into existing manual inspection stations allowing them to receive the benefits of computer aided optical inspection without the need to modify the manufacturing process to automate handling of the display. The operator’s interface provides essential views of results, images, and statistics for production floor personnel.

Results of Operations

Three Months Ended June 30, 2007 Compared with Three Months Ended June 30, 2006

Net revenues decreased $244,000 (72.2%) to $94,000 in the second quarter of 2007 from $338,000 in the second quarter of 2006. The decrease in net revenue was primarily attributable to a decrease of $196,000 in revenue from sales of our flat panel display inspection products in the second quarter of 2007 compared to $290,000 in sales from that product line in the comparable 2006 quarter. Additionally, the second quarter of 2007 included zero revenue from product development agreements; there was $48,000 of such revenues in the second quarter of 2006.

The three months ended June 30, 2007 and 2006 also had shipments of approximately $183,000 and $248,000 respectively, which were not recognized in those periods’ revenue as final acceptance had not been received from the customer.

18

Costs of sales decreased $140,000 (62.2%) to $85,000 (90.4% of sales) in the second quarter of 2007 compared to $225,000 (66.6% of sales) in the second quarter of 2006. This was primarily due to a decrease in material costs of $174,000 as a result of the lower sales of flat panel display inspection products in the 2007 period. Additionally, the second quarter of 2007 included zero costs related to product development agreements while there was $51,000 of costs in 2006.

Marketing costs decreased $31,000 (16.0%) to $163,000 in the second quarter of 2007 compared to $194,000 in the second quarter of 2006. This was attributable to decrease in trade show activity, travel and promotion costs.

General and administrative costs increased $6,000 (1.7%) to $361,000 in the second quarter of 2007 compared to $355,000 in the second quarter of 2006. We were not required to allocate any general and administrative costs to inventory or cost of goods sold for product development agreements in the second quarter of 2007. We did allocate $7,000 of general and administrative costs to cost of sales for product development agreements for the second quarter of 2006. (For more information on the allocation of certain general and administrative costs to cost of goods sold see Note B to the financial statements.) Without this allocation, general and administrative costs would have been $362,000 which is consistent with 2007 general and administrative expenses.

Engineering and development expenditures decreased $66,000 (20.0%) to $264,000 in the second quarter of 2007 compared to $330,000 in the second quarter of 2006. In the second quarter of 2006, $40,000 of engineering costs was allocated to costs of sales for product development agreements. We were not required to allocate any engineering and development costs for the second quarter of 2007. (For more information on the allocation of certain engineering costs to cost of goods sold see Note B to the financial statements.) Without this allocation, engineering costs would have decreased by $106,000 (28.7%) over the second quarter of 2006. This decrease is primarily attributable to a reduction in staffing and related costs.

Other income for the three months ended June 30, 2007 was comparable to the three months ended June 30, 2006.

Interest expense increased $79,000 to $87,000 in the second quarter of 2007 compared to $8,000 in the second quarter of 2006. The increase is primarily attributable to the issuance of Class 2 Notes in the second quarter of 2007.

Six Months Ended June 30, 2007 Compared with Six Months Ended June 30, 2006

Net revenues for the six months ended June 30, 2007 were $410,000, nearly all of which was flat panel display inspection products. Our net revenues for the six months ended June 30, 2006 were $407,000, of which $305,000 was flat panel display inspection products and $102,000 was from product development agreements; there were no such revenues in 2007.

Cost of sales for the six months ended June 30, 2007 was $346,000, nearly all of which was for our flat panel display products. Cost of sales for the six months ended June 30, 2006 was $347,000 which included costs for our flat panel display products of $243,000 and costs of $104,000 for product development agreements. There were no product development costs in 2007.

Marketing costs decreased $14,000 (4.3%) to $312,000 in 2007 compared to $326,000 in 2006. This was attributable to a decrease in trade show activity, travel and promotion costs.

General and administrative costs increased $12,000 (1.8%) to $679,000 in 2007 compared to $667,000 in 2006. General and administrative costs of $8,000 were allocated to inventory for product development agreements in 2007 while costs of $16,000 were allocated to cost of sales product development agreements for 2006. (For more information on the allocation of certain general and administrative costs to inventory and cost of goods sold, see Note B to the financial statements.) Without this allocation, general and administrative costs would have increased $4,000. Expense allocated to G&A for amortization of share

19

based compensation as required by SFAS 123R was approximately $12,000 for 2007 and approximately $21,000 for 2006.

Engineering and development expenditures decreased $77,000 (11.7%) to $580,000 in 2007 compared to $657,000 in 2006. Engineering costs of $20,000 were allocated to inventory for product development agreements in 2007 while costs of $69,000 were allocated to costs of sales product development agreements for 2006. (For more information on the allocation of certain engineering cost to inventory and cost of goods sold, see Note B to the financial statements.) Without this allocation, engineering costs would have been $600,000 for 2007 and $726,000 for 2006. The decrease of $126,000 was primarily a result of staff reductions and related benefit costs. Expense allocated to engineering and development for amortization of share based compensation as required by SFAS 123R was approximately $26,000 for 2007 and approximately $45,000 for 2006.

Other income was comparable to the prior year six month period.

Interest expense increased $96,000 to $111,000 in 2007 compared to $15,000 in 2006. The increase is primarily attributable to the issuance of additional Class 2 Notes in 2007. For more information on these notes refer to Note C of the financial statements.

Liquidity and Capital Resources

Operating activities for the six months ended June 30, 2007, used cash of approximately $1,458,000 primarily due to the Company’s loss from operations of $1,613,000

Our investing activities included the purchase of approximately $38,000 of equipment and $3,000 for patents in the six months ended June 30, 2007.

Our financing activities included proceeds of $1,560,000 from the issuance of Class 2 Notes. We paid $61,000 of principal on Class 2 Notes. We paid $15,000 of interest on Class 3 Notes.

Long-term debt, which became a current liability this quarter, consisted of $378,000 of convertible Class 3 Notes at a conversion price of $1.00. Interest on these Notes is paid semi-annually at a stated rate of 8.0% . The Class 3 Notes mature in April 2008.

The Board of Directors at their February 28, 2007 meeting authorized the issuance of up to $2,000,000 of Class 2 Notes. Effective July 23, 2007, the Board of Directors authorized an additional increase of $500,000 of Class 2 Notes. At their August 8, 2007 meeting, the Board of Directors authorized an additional increase of $122,000 of Class 2 Notes. These increases allow a total of $2,622,000 of Class 2 Notes to be outstanding.

From November 2006 through August 8, 2007, we have used $2,124,000 of Class 2 Notes to fund operations, leaving a balance of $498,000 of available Class 2 Notes which we expect to be funded during the third and fourth quarters of 2007. We anticipate needing an additional $2,000,000 to fund operations through the third quarter of 2008 and to provide working capital for anticipated orders. We are in the process of reviewing various alternatives for additional funding with potential investors. We are expecting to secure these funds and refinance the existing notes in the fourth quarter of 2007, however, there can be no assurance that this will be accomplished.

We also have an estimated $220,000 potentially owed to a certain regulatory agency as of June 30, 2007.

20

Management’s Discussion of Critical Accounting Policies

Our condensed financial statements are prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires management to make estimates and judgments that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The accounting policies discussed below are considered by management to be the most important to an understanding of our financial statements, because their application places the most significant demands on management's judgment and estimates about the effect of matters that are inherently uncertain. Our assumptions and estimates were based on the facts and circumstances known at June 30, 2007; future events rarely develop exactly as forecast, and the best estimates routinely require adjustment. These policies are also described in Note B of the Notes to Condensed Financial Statements included in this Quarterly Form 10-QSB.

Revenue Recognition

We recognize revenue in accordance with SOP 97-2, Software Revenue Recognition and Staff Accounting Bulletin No. 101 (“SAB 101”), Revenue Recognition in Financial Statements. Revenue is recognized when persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the selling price is fixed or determinable and collectibility is reasonably assured.

We account for certain product sales of its flat panel display inspection systems as multiple-element arrangements. If specific customer acceptance requirements are met, we recognize revenue for a portion of the total contract price due and billable upon shipment, with the remainder recognized when it becomes due (generally upon acceptance). We recognize all other product sales with customer acceptance provisions upon final customer acceptance. We recognize revenue from the sale of spare parts upon shipment. Revenue from service contracts is recognized over the life of the contract. Revenue is reported net of sales commissions.

Revenue is also derived through business agreements for product development. We conduct specified product development projects related to one of its principal technology specializations for an agreed-upon fee. Typically the agreements require a “best efforts” with no specified performance criteria. Revenue from product development agreements, where there are no specific performance terms, are recognized in amounts equal to the amounts expended on the programs. Generally, the agreed-upon fees for product development agreements contemplate reimbursing us, after its agreed-upon cost share, if any, for costs considered associated with project activities including expenses for direct product development and research, operating, general and administrative expenses and depreciation. Accordingly, expenses related to product development agreements are recorded as cost of revenues from product development agreements.

Inventories

Inventories are stated at the lower of standard cost, which approximates actual cost determined on a first-in, first-out basis, or market. Inventories are recorded net of allowances for unsalable or obsolete raw materials, work-in-process and finished goods. We evaluate on a quarterly basis the status of our inventory to ensure the amount recorded in our financial statements reflects the lower of our cost or the value we expect to receive when we sell the inventory. This estimate is based on several factors, including the condition and salability of our inventory and the forecasted demand for the particular products incorporating these components. Based on current backlog and expected orders, we forecast the upcoming usage of current stock. We record reserves for obsolete and slow-moving parts ranging from 0% for active parts with sufficient forecasted demand up to 100% for excess parts with insufficient demand or obsolete parts. Amounts in work-in-process and finished goods inventory typically relate to firm orders and, therefore, are not subject to obsolescence risk.

21

Impairment of Long-lived Assets

We review our long-lived assets, including property, equipment and intangibles, for impairment whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable. An impairment loss would be recognized when estimated undiscounted future cash flows expected to result from the use of the asset and its eventual disposition are less than the carrying amount of the asset.

Share Based Compensation

We account for our stock based compensation plans according to the provisions of SFAS 123-R. Accordingly, compensation costs attributable to stock options or similar equity instruments granted are measured at the fair value at the grant date, and expensed over the expected vesting period.

The fair value of each option award is estimated on the date of grant using the Black-Scholes option valuation model. The fair value of all awards is amortized on a straight line basis over the requisite service periods. The expected life of all awards granted represents the period of time that they are expected to be outstanding. The expected life is determined using historical and other information available at the time of grant. Expected volatilities are based on historical volatility of our common stock, and other factors. The risk-free rate for periods within the contractual life of the option is based on the U.S. Treasury yield curve in effect at the time of grant. We use historical data to estimate pre-vesting option forfeitures.

Contingencies and Litigation

We make an assessment of the probability of an adverse judgment resulting from current and threatened litigation. We accrue the cost of an adverse judgment if, in management’s estimation, an adverse settlement is probable and management can reasonably estimate the ultimate cost of such litigation. We have made no such accruals as of June 30, 2007.

Item 3. Controls and Procedures

a)

Evaluation of disclosure controls and procedures- Our chief executive officer and chief financial officer have each reviewed and evaluated the effectiveness of our disclosure controls and procedures (as defined in Securities Exchange Act of 1934 Rules 13a-15(e) and 15(d)- 15(e)) as of the end of the period covered by this quarterly report. Based on that evaluation, our chief executive officer and chief financial officer have each concluded that our current disclosure controls and procedures are effective to ensure that information required to be disclosed in our periodic reports filed under the Exchange Act is recorded, processed, summarized, and reported, in each case, within the time period specified by the SEC’s rules and regulations.

b)

Changes in internal controls- There have not been any significant changes in our internal controls or in other factors that could significantly affect these controls subsequent to the date of their evaluation. There were no significant deficiencies or material weakness, and therefore no corrective actions were taken.

22

PART II. OTHER INFORMATION

Item 6. Exhibits

Exhibit

Number Description of Document
3.1	Articles of Incorporation, as amended (filed as Exhibit 3.1 to the registrant's Form 10-K for the year
	ended December 31, 1995, SEC file 0-12728, and incorporated herein by reference).
3.2	Bylaws of the Registrant, as amended (filed as Exhibit 3.2 to the registrant's Form 10-K for the year
	ended December 31, 1994, SEC file 0-12728, and incorporated herein by reference).
4.1	Form of Fourth Amended Note and Warrant Purchase Agreement including Form of Integral Vision,
	Inc. Class 3 Note (filed as Exhibit 4.8 to registrant’s Form 10-K for the year ended December 31,
	2003, SEC file 0-12728, and incorporated herein by reference).
4.2	Form of Consent to Modifications dated November 14, 2006 modifying the terms of the Fourth
	Amended Note and Warrant Purchase Agreement including Form of Integral Vision, Inc. Class 2
	Warrant (filed as Exhibit 4.9 to registrant’s Form 10-Q for the quarter ended September 30, 2006,
	SEC file 0-12728, and incorporated herein by reference).
4.3	Form of Consent to Modifications dated March 6, 2007 modifying the terms of the Fourth Amended
	Note and Warrant Purchase Agreement. (filed as Exhibit 4.3 to registrant's Form 10-KSB for the
	year ended December 31, 2006. See File 0-12728 and incorporated herein by reference).
4.4	Form of Consent to Modifications dated August 13, 2007 modifying the terms of the Fourth Amended
	note and Warrant Purchase Agreement.
10.1	Incentive Stock Option Plan of the Registrant as amended (filed as Exhibit 10.4 to the registrant’s
	Form S-1 Registration Statement effective July 2, 1985, SEC File 2-98085, and incorporated herein
	by reference).
10.2	Second Incentive Stock Option Plan (filed as Exhibit 10.2 to the registrant's Form 10-K for the year
	ended December 31, 1992, SEC File 0-12728, and incorporated herein by reference).
10.3	Non-qualified Stock Option Plan (filed as Exhibit 10.3 to the registrant's Form 10-K for the year
	ended December 31, 1992, SEC File 0-12728, and incorporated herein by reference).
10.4	Amendment to Integral Vision, Inc. Incentive Stock Option Plan dated May 10, 1993 (filed as Exhibit
	10.3 to the registrant's Form 10-K for the year ended December 31, 1993, SEC File 0-12728, and
	incorporated herein by reference).
10.5	Integral Vision, Inc. Employee Stock Option Plan (filed as Exhibit 10.5 to the registrant's Form 10-Q
	for the quarter ended September 30, 1995, SEC file 0-12728, and incorporated herein by reference).
10.6	Form of Confidentiality and Non-Compete Agreement Between the Registrant and its Employees
	(filed as Exhibit 10.4 to the registrant's Form 10-K for the year ended December 31, 1992, SEC File
	0-12728, and incorporated herein by reference).
10.7	Integral Vision, Inc. 1999 Employee Stock Option Plan (filed as exhibit 10.5 to the registrant’s Form
	10-Q for the quarter ended June 30, 1999 and incorporated herein by reference).
10.8	Integral Vision, Inc. 2004 Employee Stock Option Plan (filed as exhibit 10.11 to the registrant’s Form
	10-Q for the quarter ended June 30, 2004 and incorporated herein by reference).
16	Letter regarding change in certifying accountant (filed as Exhibit 16 to registrant’s Form 10-K for the
	year ended December 31, 2002, SEC file 0-12728, and incorporated herein by reference).
31.1	Certification of Chief Executive Officer of periodic report pursuant to Rule 13a-15(e) or Rule 15d-
	15(e).
31.2	Certification of Chief Financial Officer of periodic report pursuant to Rule 13a-15(e) or Rule 15d-
	15(e).
32.1	Certification by Chief Executive Officer of Periodic Report Pursuant to 18 U.S.C. Section 1350.
32.2	Certification by Chief Financial Officer of Periodic Report Pursuant to 18 U.S.C. Section 1350.

23

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this quarterly report to be signed on its behalf by the undersigned, thereunto duly authorized.

	INTEGRAL VISION, INC.
Dated: August 14, 2007	By:	/s/ Charles J. Drake
		Charles J. Drake
		Chairman of the Board and
		Chief Executive Officer
Dated: August 14, 2007	By:	/s/Mark R. Doede
		Mark R. Doede
		President, Chief Operating Officer
		and Chief Financial Officer

24